Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Repligen Q1 2024 Adj EPS $0.28 Misses $0.30 Estimate, Sales $151.346M Beat $150.062M Estimate

Author: Benzinga Newsdesk | May 01, 2024 07:32am
Repligen (NASDAQ:RGEN) reported quarterly earnings of $0.28 per share which missed the analyst consensus estimate of $0.30 by 6.67 percent. This is a 56.25 percent decrease over earnings of $0.64 per share from the same period last year. The company reported quarterly sales of $151.346 million which beat the analyst consensus estimate of $150.062 million by 0.86 percent. This is a 17.14 percent decrease over sales of $182.660 million the same period last year.

Posted In: RGEN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist